2018 GI Symposium Presentations

The 10th annual Gastroenterology & Hepatology Symposium, being held Feb. 2-3 in Anaheim, features the following presentations by faculty members of the UCI Health H.H. Chao Comprehensive Digestive Disease Center (CDDC), as well as our honored guest speakers.

Feb. 2, 2018

Session I — GERD, Barrett’s & Cancer

8:15–8:30 a.m.
The search for the ideal paradigm for detecting and treating Barrett’s esophagus and esophageal cancer
Jason Samarasena, MD, UCI School of Medicine

8:35–8:50 a.m.
What to do about bizarre esophageal symptoms
Robert Lee, MD, UCI School of Medicine

8:55–9:10 a.m.
Endoscopic vs. surgical therapies for GERD: Is it time to put down the scalpel?
Brian Smith, MD, UCI School of Medicine

9:15–9:45 a.m.
Endoscopic surgery: POEM & beyond
Stavros Stavropoulos, MD, NYU Winthrop University Hospital

Session II — Pancreas & Biliary

12:15–12:30 p.m.
Update on pancreatic cancer
Farshid Dayyani, MD, UCI School of Medicine

12:35 –12:50 p.m.
Advances in pancreas surgery
Ronald Wolf, MD, UCI School of Medicine

12:55–1:10 p.m.
Pancreatic cystic neoplasms: Guidelines and beyond
Kenneth Chang, MD, UCI School of Medicine

Session III — Nonpolypoid (flat and depressed) colorectal neoplasm — 10 years of progress

2:50–3:20 p.m.
The nonpolypoid colorectal neoplasms: Where are we, and where are we going?
Roy Soetikno, MD, ASGE Master of Endoscopy Awardee Jakarta and Palo Alto

3:25–3:40 p.m.
Novel methods to assist detection of adenomas and sessile serrated polyps
William Karnes, MD, UCI School of Medicine

4:45–5 p.m.
Advanced techniques for resection of large polyps
John G. Lee, MD, UCI School of Medicine

5:05–5:20 p.m.
Novel robotic techniques for endoscopic resection of large polyps
Joseph Carmichael, MD, UCI School of Medicine

Feb. 3, 2018

Session IV — Hepatology

8:20–8:45 a.m.
Update on HBV treatment
Calvin Pan, MD, NYU Langone Medical Center, New York University School of Medicine

8:50–9:15 a.m.
HCV: Current management and controversies
Steven Flamm, MD, Northwestern Feinberg School of Medicine

9:20–9:45 a.m.
Update on non-alcoholic fatty liver disease
Timothy Morgan, MD, UCI School of Medicine

9:50–10:15 a.m.
Management of cirrhosis-related complications
Ke-Qin Hu, MD, UC Irvine School of Medicine

10:20–10:45 a.m.
Multidisciplinary management of hepatocellular carcinoma
Zeljka Jutric, MD, UCI School of Medicine

Session V — Inflammatory Bowel Disease

1:50–2:10 p.m.
Anti-TNF and immunomodulators in the perioperative setting
Steven Mills, MD, UCI School of Medicine

2:15–2:35 p.m.
Optimizing biologic therapies in IBD
Sandra Park, MD, UCI School of Medicine

2:40–3 p.m.
Beyond anti-TNFs: Positioning of other biologics in Crohn’s disease
Christina Ha, MD, Cedars-Sinai Medical Center

3:05–3:25 p.m.
Cancer risk with IBD therapies — how to discuss with your patients
Douglas Nguyen, MD, UCI School of Medicine